Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review

被引:12
作者
Ge, Shuwen [1 ,2 ]
Wang, Bo [1 ,2 ]
Wang, Zihao [1 ,2 ]
He, Junjian [1 ,2 ]
Ma, Xiaoxin [1 ,2 ]
机构
[1] Shengjing Hosp China Med Univ, Dept Obstet & Gynecol, Shenyang, Peoples R China
[2] Key Lab Maternal Fetal Med Liaoning Prov, Key Lab Obstet & Gynecol Higher Educ Liaoning Prov, Shenyang, Peoples R China
基金
中国国家自然科学基金;
关键词
breast cancer; ovarian cancer; endometrial cancer; cervical cancer; multiple primary cancers; primary gynecologic cancer; 2ND PRIMARY-CANCER; TERM-FOLLOW-UP; PRIMARY MALIGNANCIES; ENDOMETRIAL CANCER; MUTATION CARRIERS; OVARIAN-CANCER; FIELD CANCERIZATION; NONBREAST CANCER; WOMEN; RADIOTHERAPY;
D O I
10.3389/fonc.2022.840431
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mammary gland is closely related to the female reproductive system in many aspects, affecting the whole gynecological system. Breast cancer (BC) is the most common malignancy in women and associated with considerable negative effects. Due to various factors including co-pathogenic genetic mutations, environment factors, lifestyle, behavioral factors, treatment regimens and in-creased survival of patients with BC, there is an increased probability of developing additional primary gynecologic cancers such as ovarian cancer (OC), endometrial cancer (EC), and cervical cancer (CC). More and more studies have been conducted in recent years. Multiple primary cancers (MPCs), also known as multiple primary malignancies, refers to two or more different primary cancers in the same patient occurring in the same or different organs or tissues. The pathogenesis of multiple primary cancers is complex and has a negative effect on the prognosis and survival of patients. This review discusses the common types of BC-associated MPCs, namely, BC associated with OC, BC associated with EC and BC associated with CC, as well as risk factors, pathogenesis, treatment, and prognosis of MPCs associated with breast and gynecologic cancers. It provides new intervention and treatment ideas for patients with BC-associated MPCs to improve quality of life and prognosis.
引用
收藏
页数:12
相关论文
共 132 条
[1]  
Akram M, 2017, BIOL RES, V50
[2]   Literature Review ofBARD1as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers [J].
Alenezi, Wejdan M. ;
Fierheller, Caitlin T. ;
Recio, Neil ;
Tonin, Patricia N. .
GENES, 2020, 11 (08) :1-24
[3]   Liquid biopsy in breast cancer: A comprehensive review [J].
Alimirzaie, Sahar ;
Bagherzadeh, Maryam ;
Akbari, Mohammad R. .
CLINICAL GENETICS, 2019, 95 (06) :643-660
[4]   Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer Cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001 [J].
Andersson, Michael ;
Jensen, Maj-Britt ;
Engholm, Gerda ;
Storm, Hans Henrik .
ACTA ONCOLOGICA, 2008, 47 (04) :755-764
[5]   Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test? [J].
Angeli, Davide ;
Salvi, Samanta ;
Tedaldi, Gianluca .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
[6]   Risks of second malignancies after breast cancer treatment: Long-term results [J].
Bazire, L. ;
De Rycke, Y. ;
Asselain, B. ;
Fourquet, A. ;
Kirova, Y. M. .
CANCER RADIOTHERAPIE, 2017, 21 (01) :10-15
[7]   INCREASED RISK OF 2ND PRIMARY MALIGNANCIES IN PATIENTS WITH GYNECOLOGICAL CANCER - A SWEDISH RECORD-LINKAGE STUDY [J].
BERGFELDT, K ;
EINHORN, S ;
ROSENDAHL, I ;
HALL, P .
ACTA ONCOLOGICA, 1995, 34 (06) :771-777
[8]  
Biglia N, 2016, MINERVA GINECOL, V68, P548
[9]   Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival [J].
Biglia, Nicoletta ;
Sgandurra, Paola ;
Bounous, Valentina Elisabetta ;
Maggiorotto, Furio ;
Piva, Eleonora ;
Pivetta, Emanuele ;
Ponzone, Riccardo ;
Pasini, Barbara .
ECANCERMEDICALSCIENCE, 2016, 10
[10]   Key steps for effective breast cancer prevention [J].
Britt, Kara L. ;
Cuzick, Jack ;
Phillips, Kelly-Anne .
NATURE REVIEWS CANCER, 2020, 20 (08) :417-436